Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 2, 2002, Pages 605-610

  Song, Bi Wei ^a   Vinters, Harry V ^a   Wu, Dafang ^a   Pardridge, William M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX26; NEUROTROPHIN; STREPTAVIDIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BRAIN LEVEL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TRANSPORT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TRANSCYTOSIS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036228917     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.2.605     Document Type: Article

References (31)

1. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: Correlation to cell injury
2. Potential usefulness of basic fibroblast growth factor as a treatment for stroke
3. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats
4. In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate within brain capillary endothelium
5. Orotracheal intubation of rats by transillumination
6. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury
7. Trafermin in acute ischemic stroke: Results of a phase II/III randomized efficacy study
8. 125I-labeled basic fibroblast growth factor
9. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity
10. Clinical safety trial of intravenous basic fibroblast growth factor (bFGF, Fiblast) in acute stroke
11. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats
12. Intravenous basic fibroblast growth factor does not ameliorate brain injury resulting from transient focal ischemia in cats
13. Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate
14. Hyperglycemia and the vascular effects of cerebral ischemia
15. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor
16. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a Phase I open-label dose escalation study
17. Effect of basic fibroblast growth factor on focal ischemic injury and antioxidant enzyme activities
18. Basic fibroblast growth factor promotes in vivo cerebral angiogenesis in chronic forebrain ischemia
19. Contributions of ions and albumin to the formation and resolution of ischemic brain edema
20. Selective transport of anti-transferrin receptor antibody through the blood-brain barrier in vivo
21. Time window of infarct reduction by intravenous basic fibroblast growth factor in focal cerebral ischemia
22. Evaluation of recombinant human basic fibroblast growth factor (rhbFGF) as a cerebroprotective agent using high speed MR imaging
23. Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity
24. The fate of intravenously administered bFGF and the effect of heparin
25. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system
26. Neuroprotection with non-invasive neurotrophin delivery to brain
27. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system
28. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat
29. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin
30. Neuroprotection in transient focal brain ischemia following delayed, intravenous administration of BDNF conjugated to a blood-brain barrier drug targeting system